Literature DB >> 9576413

Thrombotic storm: when thrombosis begets thrombosis.

C S Kitchens1.   

Abstract

Patients with hypercoagulability may present with a single thrombosis and subsequently develop progressive thromboses at other sites. With inadequate therapy, the thrombotic process may self-perpetuate, leading to multiple thromboses and even death. Six cases are presented demonstrating key features of what may be termed thrombotic storm: (1) an underlying hypercoagulable disorder; (2) a provocation to initiate thrombosis; (3) rapid development of new thromboses; (4) response to prompt use of thrombolytic agent or anticoagulant therapy; and (5) remarkable good long-term prognosis if the cycle of thrombosis is interrupted. Continued activation of coagulation by fresh thrombosis is hypothesized as the cause of the syndrome, which may explain its control by anticoagulants. Whereas these unusual patients' courses most likely represent only an extreme of hypercoagulability and not a new disorder, their characteristic behavior warrants attention.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576413     DOI: 10.1016/s0002-9343(98)00061-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

Review 1.  Catastrophic antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 2.  Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.

Authors:  José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Ronald A Asherson; Mario García-Carrasco; Izaias P da Costa; Danieli C O Andrade; Eduardo F Borba; Alexander Makatsaria; Silvia Bucciarelli; Manuel Ramos-Casals; Josep Font
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

3.  Delayed catastrophic antiphospholipid syndrome after massive cerebral infarction.

Authors:  Wei Hsi Chen; Hung Sheng Lin; Yi Fen Kao; Jia Shou Liu
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 4.  Clinical and laboratory features of the catastrophic antiphospholipid syndrome.

Authors:  Ljudmila Stojanovich; Dragomir Marisavljevic; Jozef Rovensky; Aleksandra Djokovich; Darina Kozáková; Nikola Milinic
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

5.  Catastrophic antiphospholipid syndrome triggered by sepsis.

Authors:  Susan Kim; Neal K Moskowitz; Edward F DiCarlo; Anne R Bass; Doruk Erkan; Michael D Lockshin
Journal:  HSS J       Date:  2008-12-19

6.  Top 10 clinical research developments in antiphospholipid syndrome.

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

7.  Catastrophic antiphospholipid antibody syndrome following initiation of hemodialysis.

Authors:  Hideki Yotsueda; Kazuhiko Tsuruya; Masanori Tokumoto; Hideki Hirakata; Mitsuo Iida
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 8.  Treatment of catastrophic antiphospholipid syndrome.

Authors:  Nayef M Kazzaz; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

Review 9.  Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Nat Rev Rheumatol       Date:  2010-04-13       Impact factor: 20.543

10.  Accelerated arterial and venous clots in a young pregnant woman: a saga of thrombotic storm.

Authors:  Madan Raj Aryal; Madan Badal; Naresh Bhandari; Vijaya Raj Bhatt
Journal:  BMJ Case Rep       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.